Celularity Class A's chart data is dated 2026-10-09. Recorded technical signals: MA aligned. There are 3 published signal records.
Celularity Class A last closed at $1.56 (+6.85%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -0.6×. Its overall grade ranks 99 of 738 stocks in Healthcare.
About this company
Celularity Class A last closed at $1.56 (+6.85%) on 2026-10-09. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 99/738
Valuation grade B
Related stocks
- CellularityCompetitor
세포·면역치료제 개발에서 같은 바이오 경쟁군
- AthersysCompetitor
재생의학·세포치료제 영역의 경쟁사
- Fate TherapeuticsCompetitor
NK세포·면역세포 치료제 개발 경쟁사
About Celularity Class A
- What technical signals does Celularity Class A (CELU) have?
- Celularity Class A current technical signals: MA alignment (score 0.96).
- Is Celularity Class A a cup-and-handle pattern?
- No. Celularity Class A has no valid Cup signal right now.
- What published figures are available for Celularity Class A?
- Market cap: $44.19M. Trailing 12 months PER: -0.6×. Latest quarter PBR: -1.25×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Celularity Class A, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.